These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 20186691)
1. Functional evaluation of paraplegin mutations by a yeast complementation assay. Bonn F; Pantakani K; Shoukier M; Langer T; Mannan AU Hum Mutat; 2010 May; 31(5):617-21. PubMed ID: 20186691 [TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Elleuch N; Depienne C; Benomar A; Hernandez AM; Ferrer X; Fontaine B; Grid D; Tallaksen CM; Zemmouri R; Stevanin G; Durr A; Brice A Neurology; 2006 Mar; 66(5):654-9. PubMed ID: 16534102 [TBL] [Abstract][Full Text] [Related]
3. Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration. Martinelli P; La Mattina V; Bernacchia A; Magnoni R; Cerri F; Cox G; Quattrini A; Casari G; Rugarli EI Hum Mol Genet; 2009 Jun; 18(11):2001-13. PubMed ID: 19289403 [TBL] [Abstract][Full Text] [Related]
4. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Koppen M; Metodiev MD; Casari G; Rugarli EI; Langer T Mol Cell Biol; 2007 Jan; 27(2):758-67. PubMed ID: 17101804 [TBL] [Abstract][Full Text] [Related]
5. A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. Arnoldi A; Tonelli A; Crippa F; Villani G; Pacelli C; Sironi M; Pozzoli U; D'Angelo MG; Meola G; Martinuzzi A; Crimella C; Redaelli F; Panzeri C; Renieri A; Comi GP; Turconi AC; Bresolin N; Bassi MT Hum Mutat; 2008 Apr; 29(4):522-31. PubMed ID: 18200586 [TBL] [Abstract][Full Text] [Related]
6. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Sánchez-Ferrero E; Coto E; Beetz C; Gámez J; Corao AI; Díaz M; Esteban J; del Castillo E; Moris G; Infante J; Menéndez M; Pascual-Pascual SI; López de Munaín A; Garcia-Barcina MJ; Alvarez V; Clin Genet; 2013 Mar; 83(3):257-62. PubMed ID: 22571692 [TBL] [Abstract][Full Text] [Related]
7. A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects. Warnecke T; Duning T; Schirmacher A; Mohammadi S; Schwindt W; Lohmann H; Dziewas R; Deppe M; Ringelstein EB; Young P Mov Disord; 2010 Mar; 25(4):413-20. PubMed ID: 20108356 [TBL] [Abstract][Full Text] [Related]
8. [AAA ATPases and hereditary spastic paraplegia]. Wang YG; Shen L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):298-301. PubMed ID: 19504443 [TBL] [Abstract][Full Text] [Related]
10. Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. Rugarli EI; Langer T Trends Mol Med; 2006 Jun; 12(6):262-9. PubMed ID: 16647881 [TBL] [Abstract][Full Text] [Related]
11. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Wilkinson PA; Crosby AH; Turner C; Bradley LJ; Ginsberg L; Wood NW; Schapira AH; Warner TT Brain; 2004 May; 127(Pt 5):973-80. PubMed ID: 14985266 [TBL] [Abstract][Full Text] [Related]
12. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. Atorino L; Silvestri L; Koppen M; Cassina L; Ballabio A; Marconi R; Langer T; Casari G J Cell Biol; 2003 Nov; 163(4):777-87. PubMed ID: 14623864 [TBL] [Abstract][Full Text] [Related]
13. Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7. Estiar MA; Yu E; Haj Salem I; Ross JP; Mufti K; Akçimen F; Leveille E; Spiegelman D; Ruskey JA; Asayesh F; Dagher A; Yoon G; Tarnopolsky M; Boycott KM; Dupre N; Dion PA; Suchowersky O; Trempe JF; Rouleau GA; Gan-Or Z Mov Disord; 2021 Jul; 36(7):1664-1675. PubMed ID: 33598982 [TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. van Gassen KL; van der Heijden CD; de Bot ST; den Dunnen WF; van den Berg LH; Verschuuren-Bemelmans CC; Kremer HP; Veldink JH; Kamsteeg EJ; Scheffer H; van de Warrenburg BP Brain; 2012 Oct; 135(Pt 10):2994-3004. PubMed ID: 22964162 [TBL] [Abstract][Full Text] [Related]
16. Alternative splicing of Spg7, a gene involved in hereditary spastic paraplegia, encodes a variant of paraplegin targeted to the endoplasmic reticulum. Mancuso G; Barth E; Crivello P; Rugarli EI PLoS One; 2012; 7(5):e36337. PubMed ID: 22563492 [TBL] [Abstract][Full Text] [Related]
17. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration. Patron M; Sprenger HG; Langer T Cell Res; 2018 Mar; 28(3):296-306. PubMed ID: 29451229 [TBL] [Abstract][Full Text] [Related]
18. Hereditary spastic paraplegia caused by the novel mutation 1047insC in the SPG7 gene. Tzoulis C; Denora PS; Santorelli FM; Bindoff LA J Neurol; 2008 Aug; 255(8):1142-4. PubMed ID: 18563470 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel compound heterozygous SPG7 mutations-related hereditary spastic paraplegia in a Chinese family: a case report. Zhang X; Zhang L; Wu Y; Li G; Chen S; Xia Y; Li H BMC Neurol; 2018 Nov; 18(1):196. PubMed ID: 30497413 [TBL] [Abstract][Full Text] [Related]
20. A founder mutation p.H701P identified as a major cause of SPG7 in Norway. Rydning SL; Wedding IM; Koht J; Chawla M; Øye AM; Sheng Y; Vigeland MD; Selmer KK; Tallaksen CM Eur J Neurol; 2016 Apr; 23(4):763-71. PubMed ID: 26756429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]